Skip to content

Protected: Studies

A RANDOMIZED, DOUBLE-BLIND, MULTI-DOSE, PLACEBO-CONTROLLED PHASE 2/3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FASINUMAB IN PATIENTS WITH MODERATE TO SEVERE CHRONIC LOW BACK PAIN

Calendar Name R475-PN-1524
Description To evaluate the efficacy of fasinumab compared to placebo in reducing low back pain (LBP), as measured by the change from baseline at week 16 in the average daily LBP intensity (LBPI) and numerical ra
PI Thomas Schnitzer
People -
Business Administrator -
Resources 3T Trio (Neuro)
IRB STU00202182
Start Date 2016-03-25
End Date 2017-04-03
Chart String 640-5250000-60042770
Affiliates No